M&A: a crit­i­cal dri­ver for sus­tain­able top-line growth in health­care

Last week

Health eq­ui­ty in­no­va­tion must go be­yond the sci­ence

3 weeks ago

Lead­ing a Rev­o­lu­tion in Can­cer Care Means Fac­ing Health Eq­ui­ty Chal­lenges

3 weeks ago

Op­ti­miz­ing Cell and Gene Ther­a­py De­vel­op­ment and Pro­duc­tion: How Tech­nol­o­gy Providers Like Corn­ing Life Sci­ences are Spurring In­no­va­tion

Last month

Biotech in­vestors: how to find val­ue in a bear mar­ket

Last month

Process Plat­forms vs. Cus­tom Process De­vel­op­ment for AAVs and Gene Ther­a­pies

Last month

Key Trends in Dig­i­tal Ther­a­peu­tics

2 months ago

De­cen­tral­iza­tion: An Eth­i­cal Oblig­a­tion

2 months ago

Avoid­ing Cell Ther­a­py Man­u­fac­tur­ing Grid­locks — a Do’s and Don’ts Guide

2 months ago

Mea­sur­ing Re­al-World Sleep with Actig­ra­phy: Three Clin­i­cal Tri­al Use Cas­es

3 months ago

Biotech Out­look 2022: Am­ple Op­por­tu­ni­ty for a Re­bound

3 months ago

The dawn of ven­ture cap­i­tal-backed cryo-EM star­tups

3 months ago

Cen­tral­ize Clin­i­cal Tri­als with De­cen­tral­ized Clin­i­cal Tri­als

4 months ago

The four steps FU­JI­FILM Diosynth Biotech­nolo­gies is tak­ing to im­pact the fu­ture of bio­phar­ma man­u­fac­tur­ing

4 months ago

ZS Per­spec­tive: 3 Pre­dic­tions on the Fu­ture of Cell & Gene Ther­a­pies

5 months ago

The Price of Re­lief: Ex­plor­ing So­lu­tions to the Ris­ing Costs of On­col­o­gy Drugs

5 months ago

Map­ping the Fu­ture of De­cen­tral­ized Clin­i­cal Tri­als

5 months ago

The $8m Ques­tion - Why and When Pa­tients Leave the Re­cruit­ment Jour­ney

6 months ago

Hema­tol­ogy: How Far We’ve Come, Where We Go Next

6 months ago

mHealth in­no­va­tion: Iden­ti­fy­ing the best pa­tient-cen­tered tech­nol­o­gy for clin­i­cal tri­als

6 months ago

Op­ti­miz­ing Oral Drug De­liv­ery us­ing Zy­dis® Oral­ly Dis­in­te­grat­ing Tablet Tech­nol­o­gy to Ad­dress Pa­tient Chal­lenges

6 months ago

In­cor­po­rat­ing Ex­ter­nal Da­ta in­to Clin­i­cal Tri­als: Com­par­ing Dig­i­tal Twins to Ex­ter­nal Con­trol Arms

7 months ago

At the In­flec­tion Point for the Next Gen­er­a­tion of Can­cer Im­munother­a­py

7 months ago

No IND Re­quired for Cell and Gene Ther­a­py Stud­ies with Aus­tralia’s Ac­cred­it­ed CRO Avance Clin­i­cal

7 months ago
1234 Next page Last page